Alnylam already in clinic with RNAi that Genzyme has option on
This article was originally published in Scrip
Executive Summary
One of the RNAi programs covered under the recently signed deal between Alnylam Pharmaceuticals and Sanofi's Genzyme has entered clinical testing.